Published in Cancer Weekly, February 19th, 1996
If the results are confirmed, physicians are predicted to have a method for identifying otherwise unrecognized high-risk breast cancer patients who could benefit from additional treatment following surgery.
The study was led by City of Hope Executive Vice President for Medical and Scientific Affairs John S. Kovach, M.D., while at the Mayo Clinic in Rochester, Minnesota, and Mayo Clinic Medical Geneticist and Molecular Biologist Steve S. Sommer, M.D., Ph.D. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.